Related Experiment Videos
Cost effectiveness of peer support for type 2 diabetes
Paddy Gillespie1, Eamon O'Shea, Gillian Paul
1National University of Ireland, Galway. paddy.gillespie@nuigalway.ie
Summary
Group-based peer support for type 2 diabetes shows a trend toward better risk management. While not statistically significant in all measures, it appears to be a cost-effective intervention for patients.
Area of Science:
- Health Economics
- Public Health
- Diabetes Management
Background:
- Type 2 diabetes requires ongoing management to prevent complications.
- Group-based peer support interventions are being explored as a supplementary approach to standard care.
- Evaluating the cost-effectiveness of such interventions is crucial for healthcare resource allocation.
Purpose of the Study:
- To assess the cost-effectiveness of a group-based peer support intervention for type 2 diabetes patients in general practice.
- To compare the lifetime costs and benefits of peer support alongside standardized care versus standardized care alone.
Main Methods:
- An incremental cost utility analysis was performed, combining within-trial and beyond-trial data.
- A cluster randomized controlled trial involving 395 type 2 diabetes patients in Ireland formed the within-trial component.
- The United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model was used for beyond-trial analysis, with sensitivity analyses and cost-effectiveness acceptability curves.
Main Results:
- The intervention group showed a mean increase of 0.09 quality-adjusted life-years per patient.
- Healthcare costs per patient decreased by €637.43, and total costs by €623.39 compared to the control.
- The probability of the intervention being cost-effective exceeded 80% across various willingness-to-pay thresholds.
Conclusions:
- Group-based peer support demonstrated a trend towards improved risk factor management in type 2 diabetes.
- No significant differences in final cost or effectiveness endpoints were found between the intervention and control groups.
- Probabilistic analyses indicated that the peer support intervention is likely more cost-effective, with over 80% probability across potential thresholds.
Related Concept Videos
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:36Carbohydrate Metabolism
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...